IJSDR
IJSDR
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: March 2024

Volume 9 | Issue 3

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: POSSIBLE ROLE OF T-AYU-HM PREMIUM AND OTHER HERBAL DRUG TREATMENTS IN COVID19
Authors Name: Dr.Atul Desai , Dr.Hemshree Desai , Dr.Chirag Desai , Rutvij Desai
Unique Id: IJSDR2004047
Published In: Volume 5 Issue 4, April-2020
Abstract: The current scenario of pandemic Covid-19 is not a word to use lightly or carelessly. It is a word that, if underestimated, can cause unreasonable fear, or unjustified acceptance that the fight is over, leading to unnecessary suffering and death. The situation is most important for scientist across the countries for finding reasonable safe and effective solution. Lots of researches are going on for antiviral drug development; vaccine development with an ultimate goal is to fight against the novel corona virus. Till any solution comes out as boon for this infection, world health organization has mentioned specific measures to prevent the spread like social distancing, contact tracing, and quarantine for the cases and maximum testing. It is also observed that lots of researches are initiated in emphasizing role of herbal formulations or medicinal plants with allopathic drugs with synergistic actions. India has tremendous herbal drug resource and potential, routine consumption of these herbs might be the reason providing internal immunity to combat the COVID19. The time being tested herbal drug combinations may become powerful tool in fight against the COVID19. T-AYU-HM Premium is novel herbo-mineral formulations have been used in sickle cell anemia with its proven safety and efficacy data. The researchers are keen on considering the formulation application in COVID19 due to its mechanism on cellular structures. The potential of T-AYU-HM premium to maintain red blood corpuscles in sickle patients might favor its consideration in COVID19 prophylaxis and treatment with other supportive measures. Further studies are required to prove its mechanism of action as antiviral agent in COVID19. The possibilities of utilizing crucial hearbal medicine through Nasya karma is also discussed in the article.
Keywords: COVID19, T-AYU-HM Premium, Nasya, Herbo-mineral, Sickle cell anemia,
Cite Article: "POSSIBLE ROLE OF T-AYU-HM PREMIUM AND OTHER HERBAL DRUG TREATMENTS IN COVID19", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.5, Issue 4, page no.272 - 274, April-2020, Available :http://www.ijsdr.org/papers/IJSDR2004047.pdf
Downloads: 000336257
Publication Details: Published Paper ID: IJSDR2004047
Registration ID:191645
Published In: Volume 5 Issue 4, April-2020
DOI (Digital Object Identifier):
Page No: 272 - 274
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview







Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
ISSN
DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media
IJSDR

Indexing Partner